Differential Diagnosis Of Polycistic Ovaran Syndrome

1. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.

2. Lorenzo EM. Familial study of hirsutism. J Clin Endocrinol Metab 1970;31:57-73.

3. Rittmaster RS Hirsutism Lancet 1997;349:191-195.

4. Latronico AC, Chrousos GP. Extensive personal experience: Adrenocortical tumors. J Clin Endocrinol Metab 1997;82:1317-1324.

5. Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981;71:855-875.

6. Luton J-P, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognosis factor, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-1201.

7. Nader S, Hickey RC, Sellin RV, Samaan NA. Adreno cortical carcinoma: A study of 77 cases. Cancer 1983;52:707-711.

8. Bernard MH, Sidhu S, Berger N, et al. A case report in favor of a multistep adrenocortical tumorigenesis. J Clin Endocrinol Metab 2003;88:998-1001.

9. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization. Classification of Tumours. Pathology and Genetics of Endocrine Organs. IARC Press. Lyon 2004.

10. Weiss L. Comparative histologic study of 43 metastasizing and non metastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-169.

11. Seters AP van, Aalderen W, Moolenaar AJ, Gorsiro MCB, Roon F, Backer ET. Adrenocortical tumour in untreated congenital adrenocortical hyperplasia associated with adequate ACTH suppressibility. Clin Endocrinol 1981;14:325-334.

12. Pang S, Becker D, Cotelingam J, Foley TP, Drash AL. Adrenal tumor in a patient with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1981;68:242-246.

13. Beuschlein F, Reincke M, Karle M, et al. Clonal composition of human adrenocortical neoplasms. Cancer Res 1994;54:4927-4932.

14. Gicquel C, Leblond-Francillard M, Bertagna X, et al. Clonal analysis of human adrenocarcinomas and secreting adenomas. Clin Endocrinol (Oxf) 1994;40:465-477.

14a. Tavassoli FA, Devilee P. World Health Organization. Classification of Tumours. Pathology and Genetics of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.

15. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast ovarian cancer susceptibility gene BRAC1. Science 1994;266:66-71.

16. Kotlar TJ, Young RH, Albanese C, Crowley WF, Scully RE, Jameson JL. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J Clin Endocrinol Metab 1997;82:1020-1026.

17. Fuller PJ, Verity K, Shen Y, Mamers P, Jobling T, Burger HG. No evidence of a role for mutations or polymorphisms in the follicle-stimulating hormone receptot in ovarian granulosa cell tumors. J Clin Endocrinol Metab 1998;83:274-279.

18. Rossing MA, Daling JR, Weiss NS, Moore D, Self S. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-776.

19. Kristensen GB, Trpoe C. Epithelial ovarian carcinoma. Lancet 1997;349:113-117.

20. Willimsen W, Kruitwagen R, Bastaliaans B, et al. Ovaran stimulation and granulosa-cell tumour. Lancet 1993;341:986-988.

21. Godwin AK, Testa JR, Hamilton TC. The biology of ovarian cancer development. Cancer 1993;71:530-536.

22. Riman T, Persson I, Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol 1998;49:695-707.

23. Azziz R, Sanchez LA, Knochenhauer ES, et al. Andogen exces in women: experiencewith over 1000 consecutive patients. J Clin Endocrinol 2004; 89:453-462.

24. Danilowicz K, Albiger N, Vanegas M, Gomez RM, Cross G, Bruno OD. Androgen-secreting adrenal adenomas. Obstet Gynecol 2002;100:1099-1102.

25. Moreno S, Montoya G, Armstrong J, et al. Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases. Surgery 2004 136;1192-1198.

26. Young RH, Scully RE. Ovarian steroid cell tumors associated with Cushing's syndrome: A report of three cases. Int J Gynaecol Pathol 1987;6:40-48.

27. Meldrum DR, Abraham GE. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors. Obstet Gynecol 1979;53:36-43.

28. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a population study. Gynecol Endocrinol 1999;13:394-400.

29. Derksen J, Nagesser SK, Meinders AE, Haak HR, van de Velde CJH. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994;331:968-973.

30. Pugeat M, Nicolas MH, Craves J, et al. Androgens in polycystic ovary syndrome. Ann NY Acad Sci 1993;687:124-135.

31. Pascale Miras-Mirakian, Pugeat M, Robert M, et al. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin Endocrinol 1994;41:571-576.

32. Surrey ES, de Ziegler D, Gambone JC, Judd HL. Preoperative localization of androgen-secreting tumors: clinical, endocrinologic, and radiologic evaluation of ten patients. Am J Obstet Gynecol 1998;158:1313-1322.

33. Rosenfield RM, Cohen RM, Talemran A. Lipid cell tumor of the ovary in reference to adult onset congenital adrenal hyperplasic and polycystic ovary syndrome. J Reprod Med 1987;32:363-366.

34. Kaltsa GA, Isidori AM, Kola BP, et al. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab 2003;88:2634-2643.

35. Hammad A, Jasnosz KM, Olson PR. Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature. Arch Pathol Lab Med 1995;119:1075-1079.

36. Healy DL, Burger HG, Mamers P, et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 1993;329:1539-1542.

37. Robertson DM, Burger HG, Fuller PJ. Inhibin/activin and ovarian cancer. Endocrine-Related Cancer 2004;11:35-49.

38. Gustafson ML, Lee MM, Scully RE, et al. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med 1992;326:466-471.

39. Rey R, Sabourin JC, Venara M, et al. Anti-Mullerian hormone is a specific marker of sertoli-and granulosa-cell origin in gonadal tumors. Hum Pathol 2000;10:1202-1203.

40. Long WQ, Ranchin V, Pautier P, et al. Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 2000;85:540-544.

41. Kaltas GA, Mukherje JJ, Kola B, et al. Is ovarian and adrenal venous catheterization and sampling in the investigation of hyperandrogenic women? Clin Endocrinol (Oxf) 2003;59:34-43.

42. Kaltas GA, Isidori A, Besser GM, Grossman AB. Secondary forms of polycystic ovary syndrome. Trends Endocrinol Metab 2004;15:204-210.

43. Regnier C, Bennet A, Malet D, et al. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment : report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma. J Clin Endocrinol Metab 2002;87:3074-3077.

44. Roddick JW Jr, Green RR. Relation of ovarian stromal hyperplasia to endometrial carcinoma. Am J Obstet Gynecol 1957;73:843-852.

45. Haner S, Fassnacht M. Mitotane for adrenal carcinoma treatment. Curr Opin Invest Drugs 2005;6:386-394.

46. Gicquel C, Bertagna X, Le Bouc YL. Recent advances in the pathogenesis of adrenocortical tumors. Eur J Endocrinol 1995;133:133-144.

47. Libé R, Bertherat J. Molecular genetics of adrenocortical tumors, from familial to sporadic diseases. Eur J Endocrinol 2005;153:1-12.

48. Rainey WE, Sawetawan C, McCarthy JL, et al. Human ovarian tumor cells: a potential model for thecal cell steroido-genesis. J Clin Endocrinol Metab 1996;81:257-263.

49. Rayney W, Bird I, Mason J. NCI-H295R cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol 1994;100:45-50.

50. Beltran S, de Ravel R, Emptoz-Bonneton A, et al. Evaluation of the effects of a C-21 derivative of progesterone to enhance cytotoxicity of chemotherapeutic agents in a human adrenocortical carcinoma NCI H295R cell line. (Poster P1-577) 86th Annual Meeting of the Endocrine Society. New Orleans, June 16-19, 2004.

Natural Cures For Menopause

Natural Cures For Menopause

Are Menopause Symptoms Playing Havoc With Your Health and Relationships? Are you tired of the mood swings, dryness, hair loss and wrinkles that come with the change of life? Do you want to do something about it but are wary of taking the estrogen or antidepressants usually prescribed for menopause symptoms?

Get My Free Ebook

Post a comment